Komori
Medipal Holdings (7459) · RiskDropped

Litigation and Damages Risks Associated with Business Activities

First written in FY2017. 9 of 11 entries say "Restated". Latest entry: FY2022.

11entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20222017: 220172018: 420182019: 220192020: 220202021: 020212022: 12022
Same theme, other companies
Litigation and Litigation-Related Loss RiskA theme 298 companies write about · 299 as a headwind · 0 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 299 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022DroppedAnnual report
    No standalone disclosure of litigation and product liability risks arising from business activities was identified in this fiscal year's Business and Other Risks.
  2. FY2021-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  3. FY2020-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  4. FY2020-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  5. FY2019-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  6. FY2019-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  7. FY2019-Q1RestatedAnnual report

    「During the first quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  8. FY2018RestatedAnnual report

    「In the course of the Group's business activities, it may face lawsuits seeking damages.」

    The company continues to disclose litigation and product liability risks arising from business activities.
  9. FY2018-Q3RestatedAnnual report

    「No new business or other risks arose during the nine months ended [the current third quarter]. There have also been no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  10. FY2018-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there has been no material change in the litigation and product liability risks arising from business activities.
  11. FY2017First statedAnnual report

    「In the course of the Group's business activities, it may face lawsuits seeking damages.」

    The possibility of facing lawsuits seeking damages in connection with business activities was newly disclosed as a business and other risk.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medipal Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.